Ryan Gramacy's practice focuses on complex product liability litigation. He has experience representing major pharmaceutical companies in defending against personal injury claims across all aspects of litigation in state and federal courts, including dispositive motions, fact and expert discovery, and depositions. In addition to his work in complex litigation, Mr. Gramacy has also litigated matters involving patent, copyright, trademark, antitrust, and preemption issues. His experience extends to all stages of pretrial civil litigation as well as appellate proceedings.

As part of his practice, Mr. Gramacy has also supervised large discovery teams and has developed a strategic and tactical approach to managing the scope of discovery, attorney client privilege, and work product protections.

Mr. Gramacy is committed to pro bono service, having represented victims of elder abuse, fraud, and landlord-tenant harassment, as well as assisting in a federal appeal involving deliberate indifference (under the Fifth Amendment) to a prisoner's medical needs. Mr. Gramacy is also involved in the national Election Protection coalition, safeguarding voters' equal opportunity and participation in the political process.

Mr. Gramacy graduated from the University of California, Berkeley, School of Law. While in law school, Mr. Gramacy served as an Articles editor of the California Law Review, as well as a judicial extern for the Honorable John T. Noonan, Jr. of the United States Court of Appeals for the Ninth Circuit, and for the Honorable Charles R. Breyer of the United States District Court for the Northern District of California.

Prior to law school, Mr. Gramacy was a paralegal for the Habeas Corpus Resource Center, a California state entity representing indigent men and women in post-conviction habeas appeals before the Supreme Court of California.


  • Pfizer in litigation involving allegations of cerebellar atrophy related to the antiepileptic drug Dilantin®.
  • Bristol-Myers Squibb and Sanofi in multiple products liability mass actions in California concerning Plavix®. Plavix Product and Marketing Cases, Judicial Council Coordination Proceeding 4748.
  • Bristol-Myers Squibb and Sanofi in action by the Attorney General of the State of Hawaii concerning Plavix®.
  • Bristol-Myers Squibb in products liability mass actions concerning Abilify®.
  • Shoe manufacturer in a patent infringement action involving patented footwear, as well as in disputes arising under the Lanham Act, federal antitrust laws, the Computer Fraud and Abuse Act, and common law business torts.


American Jurisprudence Award
Academic Excellence in Advanced Legal Research (2015)
Witkin Award
Academic Excellence in Property Law (2014)
Academic Excellence in Legal Writing & Research (2013)


  • JD, University of California, Berkeley, School of Law, 2016
  • MSc, Psycholinguistics, The University of Edinburgh, 2006, with distinction
  • BA, Cognitive Science, University of California, Berkeley, 2004
  • California
  • US District Court, Central District of California
  • US District Court, Northern District of California
  • Completion of Pro Bono Pledge, University of California, Berkeley, School of Law

Email Disclaimer